CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-02 | Amoroso Michael President and CEO | Option exercise 10b5-1 | +283,390 | 352,128 | ||
| 2023-11-02 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −283,390 | 566,610 | ||
| 2023-11-02 | Kelly John Alexander Chief Financial Officer | Option exercise | +108,188 | 497,479 | ||
| 2023-11-02 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −108,188 | 216,312 | ||
| 2023-08-31 | Scimeca Dario General Counsel and Secretary | Grant or award | +5,443 | $0.39 | $2K | 73,916 |
| 2023-08-31 | SMITH J. JEFFERSON Chief Research Officer | Grant or award | +5,175 | $0.39 | $2K | 1,940,254 |
| 2023-08-31 | Kelly John Alexander Chief Financial Officer | Grant or award | +5,951 | $0.39 | $2K | 389,291 |
| 2023-08-18 | Kelly John Alexander Chief Financial Officer | Purchase | +90,000 | $0.48 | $43K | 383,340 |
| 2023-08-18 | Kelly John Alexander Chief Financial Officer | Grant or award | +90,000 | $0.48 | $43K | 383,340 |
| 2023-06-08 | Scimeca Dario General Counsel and Secretary | Sale 10b5-1 | −13,361 | $0.75 | $10K | 68,473 |
| 2023-06-07 | Barton Shane VP & Corporate Controller | Option exercise | +6,060 | 27,502 | ||
| 2023-06-07 | Barton Shane VP & Corporate Controller | Option exercise · Restricted Stock Units | −6,060 | 6,060 | ||
| 2023-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise | +34,091 | 279,705 | ||
| 2023-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise | +13,635 | 293,340 | ||
| 2023-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −34,091 | 0 | ||
| 2023-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −13,635 | 13,635 | ||
| 2023-06-07 | SMITH J. JEFFERSON Chief Research Officer | Option exercise | +4,872 | 1,935,079 | ||
| 2023-06-07 | SMITH J. JEFFERSON Chief Research Officer | Option exercise · Restricted Stock Units | −4,872 | 4,872 | ||
| 2023-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +22,727 | 72,790 | ||
| 2023-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +9,044 | 81,834 |
Page 12 of 23 · 456 trades